Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Humacyte, Inc. (HUMA)

$0.44 +5.40% NASDAQ: HUMA · 15-min delayed
  • DURHAM, North Carolina
  • Public · NASDAQ: HUMA
  • 184 employees
$168.5MMarket cap
$2.0MRevenue · FY2025
-$40.8MNet income
184Employees
HUMANASDAQ
2021IPO

About Humacyte, Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$2.0M
Net income
-$40.8M
Total assets
$116.4M
Market cap
$168.5M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: HUMA
$0.44 +5.40%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.35 $2.48

52-week range

Market cap
$168.5M
Shares outstanding
382.9M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 27, 2021

Humacyte, Inc. (HUMA) Stock Price

  • Reported a net loss of $40.8M in FY2025.
  • Trading 82% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Humacyte, Inc..

Write a review
Newsroom

News about Humacyte, Inc.

News & sentiment via Polygon.io

FAQ

Humacyte, Inc.: frequently asked questions

Is Humacyte, Inc. an American company?

Humacyte, Inc. is a US-based company headquartered in Durham, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Humacyte, Inc. headquartered?

Humacyte, Inc. is headquartered in Durham, North Carolina, United States.

Is Humacyte, Inc. publicly traded?

Yes — Humacyte, Inc. is a publicly traded company. Its stock trades under the ticker symbol HUMA on the NASDAQ.

What does Humacyte, Inc. do?

Humacyte, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →